• Parkinson’s Research

  Developing a Blocker of Alpha-synuclein production – Research

  Posted by Christina on December 26, 2020 at 7:20 am

  Can anyone please provide information regarding the Syn-516 study?  I believe it was being carried out by Jack Timothy Rogers, PhD.   and the principle investigator is Dr. Catherine Cahill.  connects.catalyst.harvard.edu states that it is suppose to commence on Jan. 31, 2021.   Quote, “Our most promising therapeutic compound, Syn-516…”

   

   

  Christina replied 3 years, 4 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply